About the Authors

Eva Clark

eva.clark@bcm.edu

Affiliations Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, Texas, United States of America, Department of Medicine, Section of Health Services Research, Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, Texas, United States of America, Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America

Karla Fredricks

Affiliation Section of Global and Immigrant Health, Department of Pediatrics, Texas Children’s Hospital, Baylor College of Medicine, Houston, Texas, United States of America

Laila Woc-Colburn

Affiliations Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, Texas, United States of America, Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America

Maria Elena Bottazzi

Affiliations Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America, Center for Vaccine Development, Department of Pediatrics, Texas Children’s Hospital, Baylor College of Medicine, Houston, Texas, United States of America, Departments of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America, Department of Biology, Baylor University, Waco, Texas, United States of America

Jill Weatherhead

Affiliations Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, Texas, United States of America, Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America, Center for Vaccine Development, Department of Pediatrics, Texas Children’s Hospital, Baylor College of Medicine, Houston, Texas, United States of America

Competing Interests

MEB develops vaccines for NTDs and emerging pathogens including coronavirus vaccines.